s6y

NANOMIX Corp

CIK
1473579
Industry
Pharmaceutical Preparations
Formerly
Boston Therapeutics, Inc., AVANYX Therapeutics, Inc.

Financials 72

  1. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2023
  2. 10-K Annual Report for period ending Dec 31, 2022
  3. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2022
  4. 10-Q Quarterly Report for period ending Sep 30, 2022
  5. 10-Q Quarterly Report for period ending Jun 30, 2022
  6. 10-Q Quarterly Report for period ending Mar 31, 2022
  7. NT 10-Q Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB for period ending Mar 31, 2022
  8. 10-K Annual Report for period ending Dec 31, 2021
  9. NT 10-K Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10-KT for period ending Dec 31, 2021
  10. 10-Q Quarterly Report for period ending Sep 30, 2021

All 72 financials filings

News 90

  1. 8-K Current report filing
  2. 8-K Current report filing
  3. 8-K Current report filing
  4. 8-K Current report filing
  5. 8-K Current report filing
  6. 8-K Current report filing
  7. 8-K Current report filing
  8. 8-K Current report filing
  9. 8-K Current report filing
  10. 8-K Current report filing

All 90 news filings

Ownership 70

  1. SC 13G/A Major Shareholders
  2. SC 13G/A Major Shareholders
  3. SC 13G/A Major Shareholders
  4. 3 Initial statement of beneficial ownership of securities
  5. 4 Statement of changes in beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 4 Statement of changes in beneficial ownership of securities
  8. 3 Initial statement of beneficial ownership of securities
  9. 3 Initial statement of beneficial ownership of securities
  10. 3 Initial statement of beneficial ownership of securities

All 70 ownership filings

Prospectus 34

  1. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  2. S-1/A General form of registration statement for all companies including face-amount certificate companies
  3. S-1 General form of registration statement for all companies including face-amount certificate companies
  4. 424B3 Prospectus filed pursuant to Rule 424(b)(3)
  5. S-1/A General form of registration statement for all companies including face-amount certificate companies
  6. S-1 General form of registration statement for all companies including face-amount certificate companies
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. RW Registration Withdrawal Request

All 34 prospectus filings

Proxies 8

  1. DEF 14C Definitive information statements
  2. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  3. DEF 14C Definitive information statements
  4. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition
  5. DEF 14C Definitive information statements
  6. PRER14C Preliminary revised information statements
  7. PRER14C Preliminary revised information statements
  8. PRE 14C Preliminary information statement not related to a contested matter or merger/acquisition

Other 33

  1. REVOKED
  2. EFFECT Notice of Effectiveness
  3. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  4. UPLOAD Letter (PDF)
  5. EFFECT Notice of Effectiveness
  6. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
  7. UPLOAD Letter (PDF)
  8. SC 14F1 Statement regarding change in majority of directors pursuant to Rule 14f-1
  9. D Exempt (Private) Offering
  10. D/A Exempt (Private) Offering

All 33 other filings